BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16776452)

  • 1. Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001.
    Holtz TH; Lancaster J; Laserson KF; Wells CD; Thorpe L; Weyer K
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):649-55. PubMed ID: 16776452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002.
    Shean KP; Willcox PA; Siwendu SN; Laserson KF; Gross L; Kammerer S; Wells CD; Holtz TH
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1182-9. PubMed ID: 18812049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000.
    Santha T; Garg R; Frieden TR; Chandrasekaran V; Subramani R; Gopi PG; Selvakumar N; Ganapathy S; Charles N; Rajamma J; Narayanan PR
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):780-8. PubMed ID: 12234133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso, West Africa.
    Diandé S; Sangaré L; Kouanda S; Dingtoumda BI; Mourfou A; Ouédraogo F; Sawadogo I; Nébié B; Gueye A; Sawadogo LT; Traoré AS
    Microb Drug Resist; 2009 Sep; 15(3):217-21. PubMed ID: 19728781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
    Shin SS; Pasechnikov AD; Gelmanova IY; Peremitin GG; Strelis AK; Mishustin S; Barnashov A; Karpeichik Y; Andreev YG; Golubchikova VT; Tonkel TP; Yanova GV; Nikiforov M; Yedilbayev A; Mukherjee JS; Furin JJ; Barry DJ; Farmer PE; Rich ML; Keshavjee S
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):402-8. PubMed ID: 16602404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for multidrug-resistant tuberculosis in Hong Kong.
    Law WS; Yew WW; Chiu Leung C; Kam KM; Tam CM; Chan CK; Leung CC
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1065-70. PubMed ID: 18713506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of treatment for multidrug-resistant tuberculosis in South Korea.
    Kang YA; Choi YJ; Cho YJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Respirology; 2006 Nov; 11(6):793-8. PubMed ID: 17052310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of multidrug-resistant tuberculosis in Italy.
    Ferrara G; Richeldi L; Bugiani M; Cirillo D; Besozzi G; Nutini S; Casali L; Fiorentini F; Codecasa LR; Migliori GB
    Int J Tuberc Lung Dis; 2005 May; 9(5):507-13. PubMed ID: 15875921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis.
    Bayona J; Chavez-Pachas AM; Palacios E; Llaro K; Sapag R; Becerra MC
    Int J Tuberc Lung Dis; 2003 Dec; 7(12 Suppl 3):S501-9. PubMed ID: 14677844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions.
    Jakubowiak WM; Bogorodskaya EM; Borisov SE; Danilova ID; Kourbatova EV
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):46-53. PubMed ID: 17217129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for nosocomial transmission of multidrug-resistant tuberculosis due to Mycobacterium bovis among HIV-infected patients.
    Cobo J; Asensio A; Moreno S; Navas E; Pintado V; Oliva J; Gómez-Mampaso E; Guerrero A
    Int J Tuberc Lung Dis; 2001 May; 5(5):413-8. PubMed ID: 11336271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant tuberculosis in a low-incidence region shows a high rate of transmission.
    Vázquez-Gallardo R; Anibarro L; Fernández-Villar A; Díaz-Cabanela D; Cruz-Ferro E; Pérez del Molino ML; Túñez V; Samper S; Iglesias MJ
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):429-35. PubMed ID: 17394690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.
    Laserson KF; Thorpe LE; Leimane V; Weyer K; Mitnick CD; Riekstina V; Zarovska E; Rich ML; Fraser HS; Alarcón E; Cegielski JP; Grzemska M; Gupta R; Espinal M
    Int J Tuberc Lung Dis; 2005 Jun; 9(6):640-5. PubMed ID: 15971391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public-private collaboration for multidrug-resistant tuberculosis control in New York City.
    Munsiff SS; Ahuja SD; Li J; Driver CR
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):639-48. PubMed ID: 16776451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.